Park Ha Biological Technology Co Ltd - Class A

NEW
NAS:BYAH (China)   Class A
$ 2.75 -0.050 (-1.79%) 10:10 PM EST
At Loss
P/B:
0.31
Market Cap:
$ 2.19M
Enterprise V:
$ -3.28M
Volume:
19.39K
Avg Vol (2M):
767.10K
Trade In:
Volume:
19.39K
At Loss
Avg Vol (2M):
767.10K

Business Description

Description
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
Name Current Vs Industry Vs History
Cash-To-Debt
30.41
Equity-to-Asset
0.72
Debt-to-Equity
0.04
Debt-to-EBITDA
-0.04
Interest Coverage
N/A
N/A
N/A
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-17.2
Distress
Grey
Safe
Beneish M-Score
-25.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
5.5
3-Year Book Growth Rate
174.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
38
9-Day RSI
38.71
14-Day RSI
38.4
3-1 Month Momentum %
-70.35
6-1 Month Momentum %
-80.66
12-1 Month Momentum %
-98.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.36
Quick Ratio
3.31
Cash Ratio
2.81
Days Inventory
229.29
Days Sales Outstanding
18.94
Days Payable
41.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-8.8
Shareholder Yield %
-105.34
Name Current Vs Industry Vs History
Gross Margin %
94.89
Operating Margin %
-212.11
Net Margin %
-214.11
EBITDA Margin %
-203.11
FCF Margin %
-23.03
OCF Margin %
-10.77
ROE %
-119.87
ROA %
-84.91
ROIC %
-333.09
3-Year ROIIC %
3307.88
ROC (Joel Greenblatt) %
-1611.63
ROCE %
-116.19
Years of Profitability over Past 10-Year
3
Moat Score
3
Tariff Resilience Score
4

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
0.14
PB Ratio
0.31
Price-to-Tangible-Book
0.31
EV-to-EBIT
0.61
EV-to-EBITDA
0.64
EV-to-Revenue
-1.29
EV-to-FCF
5.6
Price-to-Net-Current-Asset-Value 0.36
Price-to-Net-Cash 0.47
Earnings Yield (Greenblatt) %
163.93
FCF Yield %
-26.79

Financials (Next Earnings Date:2026-08-31 Est.)

BYAH's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BYAH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Park Ha Biological Technology Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.544
EPS (TTM) ($) -38.56
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 82.03
14-Day RSI 38.4
14-Day ATR ($) 0.624229
20-Day SMA ($) 2.99092
12-1 Month Momentum % -98.62
52-Week Range ($) 2.56 - 224
Shares Outstanding (Mil) 0.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Park Ha Biological Technology Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Park Ha Biological Technology Co Ltd Stock Events

Financials Calendars
Event Date Price ($)
First quarter earnings results for 2027 2027-01-08 In 132 days
Annual report for 2026 2026-12-18 In 111 days
General meeting for 2026 2026-10-02 10:00 In 35 days
Third quarter earnings results for 2026 2026-09-15 In 17 days
Second quarter earnings results for 2026 2026-08-31 In 2 days
0.125:1 Stock Split 2026-08-06 2.64 (+0.79%)
Annual report for 2025 2026-03-02 14.72 (+8.24%)
0.02:1 Stock Split 2026-02-20 20.36 (+1.80%)
General meeting for 2025 2025-10-03 10:00 192.12 (+2.04%)
Annual report for 2024 2025-02-24 2,176.00 (+4.31%)
Show
Entries

Park Ha Biological Technology Co Ltd Frequently Asked Questions

What is Park Ha Biological Technology Co Ltd(BYAH)'s stock price today?
The current price of BYAH is $2.75. The 52 week high of BYAH is $224.00 and 52 week low is $2.56.
When is next earnings date of Park Ha Biological Technology Co Ltd(BYAH)?
The next earnings date of Park Ha Biological Technology Co Ltd(BYAH) is 2026-08-31 Est..
Does Park Ha Biological Technology Co Ltd(BYAH) pay dividends? If so, how much?
Park Ha Biological Technology Co Ltd(BYAH) does not pay dividend.

Guru Commentaries on NAS:BYAH

No fund manager commentary yet.

Press Release

Subject Date
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH 2026-08-27
BYAH DEADLINE: SueWallSt Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline 2026-08-27
BYAH DEADLINE: SueWallSt Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline 2026-08-27
PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit 2026-08-26
Robbins LLP Urges Investors of Park Ha Biological Technology Co, Ltd. to Contact the Firm for Information About the BYAH Securities Class Action Lawsuit 2026-08-26
BYAH Shareholder Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky 2026-08-26
PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit 2026-08-21
BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact SueWallSt 2026-08-20
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH 2026-08-20
Park Ha Biological Technology Co, Ltd. Stockholders Have an Opportunity to Lead the Class Action Against BYAH- Contact Robbins LLP for Information About Recovering Your Losses 2026-08-19
10/Page

Headlines

See More
  • 1
No news.
  • 1